aluates Reports

$ 0.0

Automative

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-31J19847

BUY CHAPTERS

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-31J19847

Report

October 2025

Pages:179

QYResearch

Buy Now with 15% Discount

DESCRIPTION

TABLE OF CONTENT

TABLES & FIGURES

Blood DNA Kit Market

The global Blood DNA Kit market is projected to grow from US$ million in 2024 to US$ million by 2031, at a CAGR of %(2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

A Blood DNA Kit typically refers to a kit used for the extraction and purification of DNA from blood samples. These kits are designed to efficiently isolate DNA from various types of blood samples, including whole blood or blood components such as buffy coat or plasma.

From a downstream perspective, R&D Organisations accounted for % of 2024 revenue, surging to US$ million by 2031 (CAGR: % from 2025–2031).

Blood DNA Kit leading manufacturers including QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, etc., dominate supply; the top five capture approximately % of global revenue, with QIAGEN leading 2024 sales at US$ million.

Regional Outlook:

North America rose from US$ million in 2024 to a forecast US$ million by 2031 (CAGR %).

Asia‑Pacific will expand from US$ million to US$ million (CAGR  %), led by China (US$ million in 2024, % share rising to % by 2031), Japan (CAGR %), South Korea (CAGR %), and Southeast Asia (CAGR %).

Europe is set to grow from US$ million to US$ million (CAGR %), with Germany projected to hit US$ million by 2031 (CAGR %).

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Blood DNA Kit market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.

By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.

Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.

Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.

A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.

Market Segmentation

Scope of Blood DNA Kit Market Report

Report Metric	Details
Report Name	Blood DNA Kit Market
Segment by Type	Whole Blood Plasma or Serum Buffy Coat
Segment by Application	R&D Organisations Biotechnology Companies
Sales by Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Defines the Blood DNA Kit study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
Chapter 15: Actionable conclusions and strategic recommendations.
Why This Report:
Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

Who are the main players in the Blood DNA Kit Market report?

Ans: The main players in the Blood DNA Kit Market are QIAGEN, Thermo Fisher Scientific, Sigma-Aldrich (Merck), Roche, Axygen (Corning), Analytik Jena, Promega, Zymo Research, Illumina, Macherey-Nagel, Bio-Rad, Omega Bio-tek, Geneaid, Lucigen (Biosearch Technologies), Norgen, MGI Tech Co., Ltd., BioVision

What are the Application segmentation covered in the Blood DNA Kit Market report?

Ans: The Applications covered in the Blood DNA Kit Market report are R&D Organisations, Biotechnology Companies

What are the Type segmentation covered in the Blood DNA Kit Market report?

Ans: The Types covered in the Blood DNA Kit Market report are Whole Blood, Plasma or Serum, Buffy Coat

1 Study Coverage

1.1 Introduction to Blood DNA Kit: Definition, Properties, and Key Attributes

1.2 Market Segmentation by Type

1.2.1 Global Blood DNA Kit Market Size by Type, 2020 VS 2024 VS 2031

1.2.2 Whole Blood

1.2.3 Plasma or Serum

1.2.4 Buffy Coat

1.3 Market Segmentation by Application

1.3.1 Global Blood DNA Kit Market Size by Application, 2020 VS 2024 VS 2031

1.3.2 R&D Organisations

1.3.3 Biotechnology Companies

1.4 Assumptions and Limitations

1.5 Study Objectives

1.6 Years Considered

2 Executive Summary

2.1 Global Blood DNA Kit Revenue Estimates and Forecasts 2020-2031

2.2 Global Blood DNA Kit Revenue by Region

2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031

2.2.2 Historical and Forecasted Revenue by Region (2020--2031)

2.2.3 Global Revenue Market Share by Region (2020-2031)

2.3 Global Blood DNA Kit Sales Estimates and Forecasts 2020-2031

2.4 Global Blood DNA Kit Sales by Region

2.4.1 Sales Comparison: 2020 VS 2024 VS 2031

2.4.2 Historical and Forecasted Sales by Region (2020-2031)

2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends

2.4.4 Global Sales Market Share by Region (2020-2031)

3 Competition by Manufacturers

3.1 Global Blood DNA Kit Sales by Manufacturers

3.1.1 Global Sales Volume by Manufacturers (2020-2025)

3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)

3.2 Global Blood DNA Kit Manufacturer Revenue Rankings and Tiers

3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)

3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)

3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)

3.3 Manufacturer Profitability Profiles and Pricing Strategies

3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)

3.3.2 Manufacturer-Level Price Trends (2020-2025)

3.4 Key Manufacturers Manufacturing Base and Headquarters

3.5 Main Product Type Market Size by Manufacturers

3.5.1 Whole Blood Market Size by Manufacturers

3.5.2 Plasma or Serum Market Size by Manufacturers

3.5.3 Buffy Coat Market Size by Manufacturers

3.6 Global Blood DNA Kit Market Concentration and Dynamics

3.6.1 Global Market Concentration (CR5 and HHI)

3.6.2 Entrant/Exit Impact Analysis

3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment

4 Global Product Segmentation Analysis

4.1 Global Blood DNA Kit Sales Performance by Type

4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)

4.1.2 Global Sales Market Share by Type (2020-2031)

4.2 Global Blood DNA Kit Revenue Trends by Type

4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)

4.2.2 Global Revenue Market Share by Type (2020-2031)

4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)

4.4 Product Technology Differentiation

4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk

4.5.1 High-Growth Niches and Adoption Drivers

4.5.2 Profitability Hotspots and Cost Drivers

4.5.3 Substitution Threats

5 Global Downstream Application Analysis

5.1 Global Blood DNA Kit Sales by Application

5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)

5.1.2 Global Sales Market Share by Application (2020-2031)

5.1.3 High-Growth Application Identification

5.1.4 Emerging Application Case Studies

5.2 Global Blood DNA Kit Revenue by Application

5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)

5.2.2 Revenue Market Share by Application (2020-2031)

5.3 Global Pricing Dynamics by Application (2020-2031)

5.4 Downstream Customer Analysis

5.4.1 Top Customers by Region

5.4.2 Top Customers by Application

6 North America

6.1 North America Sales Volume and Revenue (2020-2031)

6.2 North America Key Manufacturers Sales Revenue in 2024

6.3 North America Blood DNA Kit Sales and Revenue by Type (2020-2031)

6.4 North America Blood DNA Kit Sales and Revenue by Application (2020-2031)

6.5 North America Growth Accelerators and Market Barriers

6.6 North America Blood DNA Kit Market Size by Country

6.6.1 North America Revenue by Country

6.6.2 North America Sales Trends by Country

6.6.3 US

6.6.4 Canada

6.6.5 Mexico

7 Europe

7.1 Europe Sales Volume and Revenue (2020-2031)

7.2 Europe Key Manufacturers Sales Revenue in 2024

7.3 Europe Blood DNA Kit Sales and Revenue by Type (2020-2031)

7.4 Europe Blood DNA Kit Sales and Revenue by Application (2020-2031)

7.5 Europe Growth Accelerators and Market Barriers

7.6 Europe Blood DNA Kit Market Size by Country

7.6.1 Europe Revenue by Country

7.6.2 Europe Sales Trends by Country

7.6.3 Germany

7.6.4 France

7.6.5 U.K.

7.6.6 Italy

7.6.7 Russia

8 Asia-Pacific

8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)

8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024

8.3 Asia-Pacific Blood DNA Kit Sales and Revenue by Type (2020-2031)

8.4 Asia-Pacific Blood DNA Kit Sales and Revenue by Application (2020-2031)

8.5 Asia-Pacific Blood DNA Kit Market Size by Region

8.5.1 Asia-Pacific Revenue by Region

8.5.2 Asia-Pacific Sales Trends by Region

8.6 Asia-Pacific Growth Accelerators and Market Barriers

8.7 Southeast Asia

8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)

8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines

8.8 China

8.9 Japan

8.10 South Korea

8.11 China Taiwan

8.12 India

9 Central and South America

9.1 Central and South America Sales Volume and Revenue (2020-2031)

9.2 Central and South America Key Manufacturers Sales Revenue in 2024

9.3 Central and South America Blood DNA Kit Sales and Revenue by Type (2020-2031)

9.4 Central and South America Blood DNA Kit Sales and Revenue by Application (2020-2031)

9.5 Central and South America Investment Opportunities and Key Challenges

9.6 Central and South America Blood DNA Kit Market Size by Country

9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)

9.6.2 Brazil

9.6.3 Argentina

10 Middle East and Africa

10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)

10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024

10.3 Middle East and Africa Blood DNA Kit Sales and Revenue by Type (2020-2031)

10.4 Middle East and Africa Blood DNA Kit Sales and Revenue by Application (2020-2031)

10.5 Middle East and Africa Investment Opportunities and Key Challenges

10.6 Middle East and Africa Blood DNA Kit Market Size by Country

10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)

10.6.2 GCC Countries

10.6.3 Turkey

10.6.4 Egypt

10.6.5 South Africa

11 Corporate Profile

11.1 QIAGEN

11.1.1 QIAGEN Corporation Information

11.1.2 QIAGEN Business Overview

11.1.3 QIAGEN Blood DNA Kit Product Models, Descriptions and Specifications

11.1.4 QIAGEN Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.1.5 QIAGEN Blood DNA Kit Sales by Product in 2024

11.1.6 QIAGEN Blood DNA Kit Sales by Application in 2024

11.1.7 QIAGEN Blood DNA Kit Sales by Geographic Area in 2024

11.1.8 QIAGEN Blood DNA Kit SWOT Analysis

11.1.9 QIAGEN Recent Developments

11.2 Thermo Fisher Scientific

11.2.1 Thermo Fisher Scientific Corporation Information

11.2.2 Thermo Fisher Scientific Business Overview

11.2.3 Thermo Fisher Scientific Blood DNA Kit Product Models, Descriptions and Specifications

11.2.4 Thermo Fisher Scientific Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.2.5 Thermo Fisher Scientific Blood DNA Kit Sales by Product in 2024

11.2.6 Thermo Fisher Scientific Blood DNA Kit Sales by Application in 2024

11.2.7 Thermo Fisher Scientific Blood DNA Kit Sales by Geographic Area in 2024

11.2.8 Thermo Fisher Scientific Blood DNA Kit SWOT Analysis

11.2.9 Thermo Fisher Scientific Recent Developments

11.3 Sigma-Aldrich (Merck)

11.3.1 Sigma-Aldrich (Merck) Corporation Information

11.3.2 Sigma-Aldrich (Merck) Business Overview

11.3.3 Sigma-Aldrich (Merck) Blood DNA Kit Product Models, Descriptions and Specifications

11.3.4 Sigma-Aldrich (Merck) Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.3.5 Sigma-Aldrich (Merck) Blood DNA Kit Sales by Product in 2024

11.3.6 Sigma-Aldrich (Merck) Blood DNA Kit Sales by Application in 2024

11.3.7 Sigma-Aldrich (Merck) Blood DNA Kit Sales by Geographic Area in 2024

11.3.8 Sigma-Aldrich (Merck) Blood DNA Kit SWOT Analysis

11.3.9 Sigma-Aldrich (Merck) Recent Developments

11.4 Roche

11.4.1 Roche Corporation Information

11.4.2 Roche Business Overview

11.4.3 Roche Blood DNA Kit Product Models, Descriptions and Specifications

11.4.4 Roche Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.4.5 Roche Blood DNA Kit Sales by Product in 2024

11.4.6 Roche Blood DNA Kit Sales by Application in 2024

11.4.7 Roche Blood DNA Kit Sales by Geographic Area in 2024

11.4.8 Roche Blood DNA Kit SWOT Analysis

11.4.9 Roche Recent Developments

11.5 Axygen (Corning)

11.5.1 Axygen (Corning) Corporation Information

11.5.2 Axygen (Corning) Business Overview

11.5.3 Axygen (Corning) Blood DNA Kit Product Models, Descriptions and Specifications

11.5.4 Axygen (Corning) Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.5.5 Axygen (Corning) Blood DNA Kit Sales by Product in 2024

11.5.6 Axygen (Corning) Blood DNA Kit Sales by Application in 2024

11.5.7 Axygen (Corning) Blood DNA Kit Sales by Geographic Area in 2024

11.5.8 Axygen (Corning) Blood DNA Kit SWOT Analysis

11.5.9 Axygen (Corning) Recent Developments

11.6 Analytik Jena

11.6.1 Analytik Jena Corporation Information

11.6.2 Analytik Jena Business Overview

11.6.3 Analytik Jena Blood DNA Kit Product Models, Descriptions and Specifications

11.6.4 Analytik Jena Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.6.5 Analytik Jena Recent Developments

11.7 Promega

11.7.1 Promega Corporation Information

11.7.2 Promega Business Overview

11.7.3 Promega Blood DNA Kit Product Models, Descriptions and Specifications

11.7.4 Promega Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.7.5 Promega Recent Developments

11.8 Zymo Research

11.8.1 Zymo Research Corporation Information

11.8.2 Zymo Research Business Overview

11.8.3 Zymo Research Blood DNA Kit Product Models, Descriptions and Specifications

11.8.4 Zymo Research Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.8.5 Zymo Research Recent Developments

11.9 Illumina

11.9.1 Illumina Corporation Information

11.9.2 Illumina Business Overview

11.9.3 Illumina Blood DNA Kit Product Models, Descriptions and Specifications

11.9.4 Illumina Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.9.5 Illumina Recent Developments

11.10 Macherey-Nagel

11.10.1 Macherey-Nagel Corporation Information

11.10.2 Macherey-Nagel Business Overview

11.10.3 Macherey-Nagel Blood DNA Kit Product Models, Descriptions and Specifications

11.10.4 Macherey-Nagel Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.10.5 Macherey-Nagel Recent Developments

11.11 Bio-Rad

11.11.1 Bio-Rad Corporation Information

11.11.2 Bio-Rad Business Overview

11.11.3 Bio-Rad Blood DNA Kit Product Models, Descriptions and Specifications

11.11.4 Bio-Rad Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.11.5 Bio-Rad Recent Developments

11.12 Omega Bio-tek

11.12.1 Omega Bio-tek Corporation Information

11.12.2 Omega Bio-tek Business Overview

11.12.3 Omega Bio-tek Blood DNA Kit Product Models, Descriptions and Specifications

11.12.4 Omega Bio-tek Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.12.5 Omega Bio-tek Recent Developments

11.13 Geneaid

11.13.1 Geneaid Corporation Information

11.13.2 Geneaid Business Overview

11.13.3 Geneaid Blood DNA Kit Product Models, Descriptions and Specifications

11.13.4 Geneaid Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.13.5 Geneaid Recent Developments

11.14 Lucigen (Biosearch Technologies)

11.14.1 Lucigen (Biosearch Technologies) Corporation Information

11.14.2 Lucigen (Biosearch Technologies) Business Overview

11.14.3 Lucigen (Biosearch Technologies) Blood DNA Kit Product Models, Descriptions and Specifications

11.14.4 Lucigen (Biosearch Technologies) Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.14.5 Lucigen (Biosearch Technologies) Recent Developments

11.15 Norgen

11.15.1 Norgen Corporation Information

11.15.2 Norgen Business Overview

11.15.3 Norgen Blood DNA Kit Product Models, Descriptions and Specifications

11.15.4 Norgen Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.15.5 Norgen Recent Developments

11.16 MGI Tech Co., Ltd.

11.16.1 MGI Tech Co., Ltd. Corporation Information

11.16.2 MGI Tech Co., Ltd. Business Overview

11.16.3 MGI Tech Co., Ltd. Blood DNA Kit Product Models, Descriptions and Specifications

11.16.4 MGI Tech Co., Ltd. Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.16.5 MGI Tech Co., Ltd. Recent Developments

11.17 BioVision

11.17.1 BioVision Corporation Information

11.17.2 BioVision Business Overview

11.17.3 BioVision Blood DNA Kit Product Models, Descriptions and Specifications

11.17.4 BioVision Blood DNA Kit Sales, Price, Revenue and Gross Margin (2020-2025)

11.17.5 BioVision Recent Developments

12 Value Chain and Supply-Chain Analysis

12.1 Blood DNA Kit Industry Chain

12.2 Blood DNA Kit Upstream Materials Analysis

12.2.1 Raw Materials

12.2.2 Key Suppliers Market Share & Risk Assessment

12.3 Blood DNA Kit Integrated Production Analysis

12.3.1 Manufacturing Footprint Analysis

12.3.2 Regional Production Market Share (2020-2031)

12.3.3 Regulatory and Trade Policy Impact on Production

12.3.4 Production Technology Overview

12.3.5 Regional Cost Drivers

12.4 Blood DNA Kit Sales Channels and Distribution Networks

12.4.1 Sales Channels

12.4.2 Distributors

13 Blood DNA Kit Market Dynamics

13.1 Industry Trends and Evolution

13.2 Market Growth Drivers and Emerging Opportunities

13.3 Market Challenges, Risks, and Restraints

14 Key Findings in the Global Blood DNA Kit Study

15 Appendix

15.1 Research Methodology

15.1.1 Methodology/Research Approach

15.1.1.1 Research Programs/Design

15.1.1.2 Market Size Estimation

15.1.1.3 Market Breakdown and Data Triangulation

15.1.2 Data Source

15.1.2.1 Secondary Sources

15.1.2.2 Primary Sources

15.2 Author Details

List of Tables

Table 1. Global Blood DNA Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Table 2. Global Blood DNA Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Table 3. Global Blood DNA Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 4. Global Blood DNA Kit Revenue by Region (2020-2025) & (US$ Million)

Table 5. Global Blood DNA Kit Revenue by Region (2026-2031) & (US$ Million)

Table 6. Global Blood DNA Kit Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Units)

Table 7. Global Blood DNA Kit Sales by Region (2020-2025) & (K Units)

Table 8. Global Blood DNA Kit Sales by Region (2026-2031) & (K Units)

Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 10. Global Blood DNA Kit Sales by Manufacturers (2020-2025) & (K Units)

Table 11. Global Blood DNA Kit Sales Share by Manufacturers (2020-2025)

Table 12. Global Blood DNA Kit Revenue by Manufacturers (2020-2025) & (US$ Million)

Table 13. Global Blood DNA Kit Revenue Market Share by Manufacturers (2020-2025)

Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)

Table 15. Global Blood DNA Kit by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Blood DNA Kit as of 2024)

Table 16. Global Blood DNA Kit Average Gross Margin (%) by Manufacturer (2020 VS 2024)

Table 17. Global Blood DNA Kit Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Unit)

Table 18. Key Manufacturers Blood DNA Kit Manufacturing Base and Headquarters

Table 19. Global Blood DNA Kit Market Concentration Ratio (CR5 and HHI)

Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis

Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment

Table 22. Global Blood DNA Kit Sales by Type (2020-2025) & (K Units)

Table 23. Global Blood DNA Kit Sales by Type (2026-2031) & (K Units)

Table 24. Global Blood DNA Kit Revenue by Type (2020-2025) & (US$ Million)

Table 25. Global Blood DNA Kit Revenue by Type (2026-2031) & (US$ Million)

Table 26. Global Blood DNA Kit ASP by Type (2020-2031) & (US$/Unit)

Table 27. Technical Specifications by Key Product Type

Table 28. Global Blood DNA Kit Sales by Application (2020-2025) & (K Units)

Table 29. Global Blood DNA Kit Sales by Application (2026-2031) & (K Units)

Table 30. Blood DNA Kit High-Growth Sectors Demand CAGR (2024-2031)

Table 31. Global Blood DNA Kit Revenue by Application (2020-2025) & (US$ Million)

Table 32. Global Blood DNA Kit Revenue by Application (2026-2031) & (US$ Million)

Table 33. Global Blood DNA Kit ASP by Application (2020-2031) & (US$/Unit)

Table 34. Top Customers by Region

Table 35. Top Customers by Application

Table 36. North America Blood DNA Kit Growth Accelerators and Market Barriers

Table 37. North America Blood DNA Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 38. North America Blood DNA Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 39. Europe Blood DNA Kit Growth Accelerators and Market Barriers

Table 40. Europe Blood DNA Kit Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)

Table 41. Europe Blood DNA Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 42. Asia-Pacific Blood DNA Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 43. Asia-Pacific Blood DNA Kit Sales (K Units) by Country (2020 VS 2024 VS 2031)

Table 44. Asia-Pacific Blood DNA Kit Growth Accelerators and Market Barriers

Table 45. Southeast Asia Blood DNA Kit Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Table 46. Central and South America Blood DNA Kit Investment Opportunities and Key Challenges

Table 47. Central and South America Blood DNA Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 48. Middle East and Africa Blood DNA Kit Investment Opportunities and Key Challenges

Table 49. Middle East and Africa Blood DNA Kit Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)

Table 50. QIAGEN Corporation Information

Table 51. QIAGEN Description and Major Businesses

Table 52. QIAGEN Product Models, Descriptions and Specifications

Table 53. QIAGEN Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 54. QIAGEN Sales Value Proportion by Product in 2024

Table 55. QIAGEN Sales Value Proportion by Application in 2024

Table 56. QIAGEN Sales Value Proportion by Geographic Area in 2024

Table 57. QIAGEN Blood DNA Kit SWOT Analysis

Table 58. QIAGEN Recent Developments

Table 59. Thermo Fisher Scientific Corporation Information

Table 60. Thermo Fisher Scientific Description and Major Businesses

Table 61. Thermo Fisher Scientific Product Models, Descriptions and Specifications

Table 62. Thermo Fisher Scientific Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 63. Thermo Fisher Scientific Sales Value Proportion by Product in 2024

Table 64. Thermo Fisher Scientific Sales Value Proportion by Application in 2024

Table 65. Thermo Fisher Scientific Sales Value Proportion by Geographic Area in 2024

Table 66. Thermo Fisher Scientific Blood DNA Kit SWOT Analysis

Table 67. Thermo Fisher Scientific Recent Developments

Table 68. Sigma-Aldrich (Merck) Corporation Information

Table 69. Sigma-Aldrich (Merck) Description and Major Businesses

Table 70. Sigma-Aldrich (Merck) Product Models, Descriptions and Specifications

Table 71. Sigma-Aldrich (Merck) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 72. Sigma-Aldrich (Merck) Sales Value Proportion by Product in 2024

Table 73. Sigma-Aldrich (Merck) Sales Value Proportion by Application in 2024

Table 74. Sigma-Aldrich (Merck) Sales Value Proportion by Geographic Area in 2024

Table 75. Sigma-Aldrich (Merck) Blood DNA Kit SWOT Analysis

Table 76. Sigma-Aldrich (Merck) Recent Developments

Table 77. Roche Corporation Information

Table 78. Roche Description and Major Businesses

Table 79. Roche Product Models, Descriptions and Specifications

Table 80. Roche Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 81. Roche Sales Value Proportion by Product in 2024

Table 82. Roche Sales Value Proportion by Application in 2024

Table 83. Roche Sales Value Proportion by Geographic Area in 2024

Table 84. Roche Blood DNA Kit SWOT Analysis

Table 85. Roche Recent Developments

Table 86. Axygen (Corning) Corporation Information

Table 87. Axygen (Corning) Description and Major Businesses

Table 88. Axygen (Corning) Product Models, Descriptions and Specifications

Table 89. Axygen (Corning) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 90. Axygen (Corning) Sales Value Proportion by Product in 2024

Table 91. Axygen (Corning) Sales Value Proportion by Application in 2024

Table 92. Axygen (Corning) Sales Value Proportion by Geographic Area in 2024

Table 93. Axygen (Corning) Blood DNA Kit SWOT Analysis

Table 94. Axygen (Corning) Recent Developments

Table 95. Analytik Jena Corporation Information

Table 96. Analytik Jena Description and Major Businesses

Table 97. Analytik Jena Product Models, Descriptions and Specifications

Table 98. Analytik Jena Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 99. Analytik Jena Recent Developments

Table 100. Promega Corporation Information

Table 101. Promega Description and Major Businesses

Table 102. Promega Product Models, Descriptions and Specifications

Table 103. Promega Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 104. Promega Recent Developments

Table 105. Zymo Research Corporation Information

Table 106. Zymo Research Description and Major Businesses

Table 107. Zymo Research Product Models, Descriptions and Specifications

Table 108. Zymo Research Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 109. Zymo Research Recent Developments

Table 110. Illumina Corporation Information

Table 111. Illumina Description and Major Businesses

Table 112. Illumina Product Models, Descriptions and Specifications

Table 113. Illumina Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 114. Illumina Recent Developments

Table 115. Macherey-Nagel Corporation Information

Table 116. Macherey-Nagel Description and Major Businesses

Table 117. Macherey-Nagel Product Models, Descriptions and Specifications

Table 118. Macherey-Nagel Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 119. Macherey-Nagel Recent Developments

Table 120. Bio-Rad Corporation Information

Table 121. Bio-Rad Description and Major Businesses

Table 122. Bio-Rad Product Models, Descriptions and Specifications

Table 123. Bio-Rad Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 124. Bio-Rad Recent Developments

Table 125. Omega Bio-tek Corporation Information

Table 126. Omega Bio-tek Description and Major Businesses

Table 127. Omega Bio-tek Product Models, Descriptions and Specifications

Table 128. Omega Bio-tek Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 129. Omega Bio-tek Recent Developments

Table 130. Geneaid Corporation Information

Table 131. Geneaid Description and Major Businesses

Table 132. Geneaid Product Models, Descriptions and Specifications

Table 133. Geneaid Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 134. Geneaid Recent Developments

Table 135. Lucigen (Biosearch Technologies) Corporation Information

Table 136. Lucigen (Biosearch Technologies) Description and Major Businesses

Table 137. Lucigen (Biosearch Technologies) Product Models, Descriptions and Specifications

Table 138. Lucigen (Biosearch Technologies) Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 139. Lucigen (Biosearch Technologies) Recent Developments

Table 140. Norgen Corporation Information

Table 141. Norgen Description and Major Businesses

Table 142. Norgen Product Models, Descriptions and Specifications

Table 143. Norgen Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 144. Norgen Recent Developments

Table 145. MGI Tech Co., Ltd. Corporation Information

Table 146. MGI Tech Co., Ltd. Description and Major Businesses

Table 147. MGI Tech Co., Ltd. Product Models, Descriptions and Specifications

Table 148. MGI Tech Co., Ltd. Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 149. MGI Tech Co., Ltd. Recent Developments

Table 150. BioVision Corporation Information

Table 151. BioVision Description and Major Businesses

Table 152. BioVision Product Models, Descriptions and Specifications

Table 153. BioVision Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2020-2025)

Table 154. BioVision Recent Developments

Table 155. Key Raw Materials Distribution

Table 156. Raw Materials Key Suppliers

Table 157. Critical Raw Material Supplier Concentration (2024) & Risk Index

Table 158. Milestones in Production Technology Evolution

Table 159. Distributors List

Table 160. Market Trends and Market Evolution

Table 161. Market Drivers and Opportunities

Table 162. Market Challenges, Risks, and Restraints

Table 163. Research Programs/Design for This Report

Table 164. Key Data Information from Secondary Sources

Table 165. Key Data Information from Primary Sources

List of Figures

Figure 1. Blood DNA Kit Product Picture

Figure 2. Global Blood DNA Kit Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)

Figure 3. Whole Blood Product Picture

Figure 4. Plasma or Serum Product Picture

Figure 5. Buffy Coat Product Picture

Figure 6. Global Blood DNA Kit Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)

Figure 7. R&D Organisations

Figure 8. Biotechnology Companies

Figure 9. Blood DNA Kit Report Years Considered

Figure 10. Global Blood DNA Kit Revenue, (US$ Million), 2020 VS 2024 VS 2031

Figure 11. Global Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 12. Global Blood DNA Kit Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)

Figure 13. Global Blood DNA Kit Revenue Market Share by Region (2020-2031)

Figure 14. Global Blood DNA Kit Sales (2020-2031) & (K Units)

Figure 15. Global Blood DNA Kit Sales (CAGR) by Region (2020-2031) (K Units)

Figure 16. Global Blood DNA Kit Sales Market Share by Region (2020-2031)

Figure 17. Top 5 and Top 10 Manufacturers Blood DNA Kit Sales Volume Market Share in 2024

Figure 18. Global Blood DNA Kit Revenue Market Share Ranking (2024)

Figure 19. Tier Distribution by Revenue Contribution (2020 VS 2024)

Figure 20. Whole Blood Revenue Market Share by Manufacturer in 2024

Figure 21. Plasma or Serum Revenue Market Share by Manufacturer in 2024

Figure 22. Buffy Coat Revenue Market Share by Manufacturer in 2024

Figure 23. Global Blood DNA Kit Sales Market Share by Type (2020-2031)

Figure 24. Global Blood DNA Kit Revenue Market Share by Type (2020-2031)

Figure 25. Global Blood DNA Kit Sales Market Share by Application (2020-2031)

Figure 26. Global Blood DNA Kit Revenue Market Share by Application (2020-2031)

Figure 27. North America Blood DNA Kit Sales YoY (2020-2031) & (K Units)

Figure 28. North America Blood DNA Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 29. North America Top 5 Manufacturers Blood DNA Kit Sales Revenue (US$ Million) in 2024

Figure 30. North America Blood DNA Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 31. North America Blood DNA Kit Sales Revenue (US$ Million) by Type (2020 - 2031)

Figure 32. North America Blood DNA Kit Sales Volume (K Units) by Application (2020-2031)

Figure 33. North America Blood DNA Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 34. US Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 35. Canada Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 36. Mexico Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 37. Europe Blood DNA Kit Sales YoY (2020-2031) & (K Units)

Figure 38. Europe Blood DNA Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 39. Europe Top 5 Manufacturers Blood DNA Kit Sales Revenue (US$ Million) in 2024

Figure 40. Europe Blood DNA Kit Sales Volume (K Units) by Type (2020-2031)

Figure 41. Europe Blood DNA Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 42. Europe Blood DNA Kit Sales Volume (K Units) by Application (2020-2031)

Figure 43. Europe Blood DNA Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 44. Germany Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 45. France Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 46. U.K. Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 47. Italy Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 48. Russia Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 49. Asia-Pacific Blood DNA Kit Sales YoY (2020-2031) & (K Units)

Figure 50. Asia-Pacific Blood DNA Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 51. Asia-Pacific Top 8 Manufacturers Blood DNA Kit Sales Revenue (US$ Million) in 2024

Figure 52. Asia-Pacific Blood DNA Kit Sales Volume (K Units) by Type (2020- 2031)

Figure 53. Asia-Pacific Blood DNA Kit Sales Revenue (US$ Million) by Type (2020- 2031)

Figure 54. Asia-Pacific Blood DNA Kit Sales Volume (K Units) by Application (2020-2031)

Figure 55. Asia-Pacific Blood DNA Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 56. Indonesia Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 57. Japan Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 58. South Korea Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 59. China Taiwan Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 60. India Blood DNA Kit Revenue (2020-2031) & (US$ Million)

Figure 61. Central and South America Blood DNA Kit Sales YoY (2020-2031) & (K Units)

Figure 62. Central and South America Blood DNA Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 63. Central and South America Top 5 Manufacturers Blood DNA Kit Sales Revenue (US$ Million) in 2024

Figure 64. Central and South America Blood DNA Kit Sales Volume (K Units) by Type (2021-2031)

Figure 65. Central and South America Blood DNA Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 66. Central and South America Blood DNA Kit Sales Volume (K Units) by Application (2020-2031)

Figure 67. Central and South America Blood DNA Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 68. Brazil Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 69. Argentina Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 70. Middle East, and Africa Blood DNA Kit Sales YoY (2020-2031) & (K Units)

Figure 71. Middle East and Africa Blood DNA Kit Revenue YoY (2020-2031) & (US$ Million)

Figure 72. Middle East and Africa Top 5 Manufacturers Blood DNA Kit Sales Revenue (US$ Million) in 2024

Figure 73. Middle East and Africa Blood DNA Kit Sales Volume (K Units) by Type (2021-2031)

Figure 74. South America Blood DNA Kit Sales Revenue (US$ Million) by Type (2020-2031)

Figure 75. Middle East and Africa Blood DNA Kit Sales Volume (K Units) by Application (2020-2031)

Figure 76. Middle East and Africa Blood DNA Kit Sales Revenue (US$ Million) by Application (2020-2031)

Figure 77. GCC Countries Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 78. Turkey Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 79. Egypt Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 80. South Africa Blood DNA Kit Revenue (2020-2025) & (US$ Million)

Figure 81. Blood DNA Kit Industry Chain Mapping

Figure 82. Regional Blood DNA Kit Manufacturing Base Distribution (%)

Figure 83. Global Blood DNA Kit Production Market Share by Region (2020-2031)

Figure 84. Blood DNA Kit Production Process

Figure 85. Regional Blood DNA Kit Production Cost Structure

Figure 86. Channels of Distribution (Direct Vs Distribution)

Figure 87. Bottom-up and Top-down Approaches for This Report

Figure 88. Data Triangulation

Figure 89. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$4900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Epigenetic Analysis Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-17Y20100

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

120 Pages

Type: Report

Code: QYRE-Auto-31J19847

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Pancreatic Enzyme Functional Assay Kit Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-33U19833

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

Global Plant Genetic Engineering Services Market Research Report 2025

120 Pages

Type: Report

Code: QYRE-Auto-26Y19619

Tue Oct 14 00:00:00 UTC 2025

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

Published Date: October 2025

Report Code: QYRE-Auto-31J19847

Global Blood DNA Kit Market Outlook, In‑Depth Analysis & Forecast to 2031

FEATURED COMPANIES

Blood DNA Kit Market

Report Includes:

Scope of Blood DNA Kit Market Report

Chapter Outline

FAQ for this report

Who are the main players in the Blood DNA Kit Market report?

What are the Application segmentation covered in the Blood DNA Kit Market report?

What are the Type segmentation covered in the Blood DNA Kit Market report?

FEATURED COMPANIES

RELATED REPORTS